Anticancer Drug???Induced Kidney Disorders
- 1 January 2001
- journal article
- review article
- Published by Springer Nature in Drug Safety
- Vol. 24 (1), 19-38
- https://doi.org/10.2165/00002018-200124010-00003
Abstract
Nephrotoxicity is an inherent adverse effect of certain anticancer drugs. Renal dysfunction can be categorised as prerenal uraemia, intrinsic damage or postrenal uraemia according to the underlying...Keywords
This publication has 139 references indexed in Scilit:
- Pilot study of high-dose vincristine, etoposide, carboplatin and melphalan with autologous bone marrow rescue in advanced neuroblastomaEuropean Journal Of Cancer, 1992
- Toxicity of single-day high-dose vincristine, melphalan, etoposide and carboplatin consolidation with autologous bone marrow rescue in advanced neuroblastomaEuropean Journal Of Cancer, 1992
- Ifosfamide-induced renal tubular dysfunction and rickets in children with Wilms tumorThe Journal of Pediatrics, 1990
- IFOSFAMIDE-INDUCED FANCONI SYNDROMEThe Lancet, 1989
- Acute Renal Failure after High-Dose Methotrexate TherapyNephron, 1989
- A Progress Report on the Treatment of 157 Patients with Advanced Cancer Using Lymphokine-Activated Killer Cells and Interleukin-2 or High-Dose Interleukin-2 AloneNew England Journal of Medicine, 1987
- In vivo studies on the relationship between hepatic metabolism and the renal toxicity of 1-(2-chloroethyl)-3-(trans-4-methylcyclohexyl)-1-nitrosourea (MeCCNU)Toxicology and Applied Pharmacology, 1986
- Renal toxicity of cisplatin in childrenThe Journal of Pediatrics, 1985
- Chronic Renal Failure in Children Treated with Methyl CCNUNew England Journal of Medicine, 1979
- Use of Serum Creatinine Concentrations to Determine Renal Function1Clinical Pharmacokinetics, 1979